According to a recent SEC filing, the largest stake held by Soros Fund Management is a $544.8 million stake in Teva Pharmaceutical Industries Limited.
According to the companies web site:
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients.Other major players have bought a stake in Teva, including Paul Tudor Jones, Jeremy Grantham, John Keeley and Ken Heebner. They have all bought the stock in the first quarter of 2014.
Headquartered in Israel, Teva is the world’s leading generic drug maker, with a global product portfolio of more than 1,000, molecules and a direct presence in approximately 60 countries. Teva’s branded businesses focus on CNS, oncology, pain respiratory and women’s health therapeutic areas as well as biologics. Teva currently employs approximately 45,000 people around the world and reached $20.3 billion in net tevenues in 2013. Teva’s net revenues for the first quarter of 2014 amounted to $ 5.0 billion.
-RW
Here's my two guesses.
ReplyDelete1. They came up with a weed related cancer cure.
or
2. They think they will get granted rights to produce generic Sovaldi because state governments are going bankrupt paying to treat people with it under indigent care programs.